Go Pro
→ MILLIONAIRE MASTERCLASS INVITE: Altucher (From Paradigm Press) (Ad)tc pixel Free WGS Stock Alerts

GeneDx (WGS) Short Interest Ratio & Short Volume

GeneDx logo
$70.96 -1.34 (-1.85%)
Closing price 10/1/2026 04:00 PM Eastern
Extended Trading
$70.74 -0.22 (-0.31%)
As of 05:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

GeneDx Short Interest Overview

As of September 15, 2026, GeneDx (WGS) had a short interest of 5.88 million shares sold short, representing 26.37% of the public float. This marks a -1.94% decrease in short interest since the prior report. The short interest ratio (days to cover) is 12.1, meaning it would take 12.1 days of the average trading volume of 735,486 shares to cover all short positions.

Current Short Interest
5,884,765 shares
Previous Short Interest
6,001,270 shares
Change Vs. Previous Month
-1.94%
Dollar Volume Sold Short
$556.93 million
Short Interest Ratio
12.1 Days to Cover
Last Record Date
September 15, 2026
Outstanding Shares
29,820,000 shares
Short Percent of Float
26.37%
Today's Trading Volume
858,016 shares
Average Trading Volume
735,486 shares
Today's Volume Vs. Average
117%
Short Selling GeneDx?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for GeneDx and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

WGS Short Interest Over Time

WGS Days to Cover Over Time

WGS Percentage of Float Shorted Over Time

GeneDx Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/20265,884,765 shares $556.93 million -1.9%26.4%12.09 $94.64
8/31/20266,001,270 shares $508.97 million -4.6%26.9%12.43 $84.81
8/14/20266,289,158 shares $491.06 million +7.5%28.2%6.39 $78.08
7/31/20265,848,506 shares $380.80 million +0.3%26.2%8.58 $65.11
7/15/20265,830,669 shares $385.64 million -1.8%26.2%8.43 $66.14
6/30/20265,940,039 shares $407.78 million -1.2%26.7%5.9 $68.65
6/15/20266,010,473 shares $368.56 million +31.5%27.1%4.93 $61.32
5/29/20264,571,456 shares $237.67 million -7.3%21.9%3.44 $51.99
5/15/20264,932,190 shares $200.99 million +16.8%23.6%1.68 $40.75
4/30/20264,222,620 shares $265.56 million +6.6%20.2%7.75 $62.89
4/15/20263,961,991 shares $267.28 million +0.5%17.8%6.13 $67.46
3/31/20263,943,616 shares $253.26 million +2.1%17.8%5.3 $64.22
3/13/20263,864,036 shares $300.54 million +10.4%18.7%4.6 $77.78
2/27/20263,499,873 shares $278.97 million -7.9%17.0%5.21 $79.71
2/13/20263,801,831 shares $342.74 million +5.1%17.1%4.74 $90.15
1/30/20263,618,363 shares $348.30 million -0.1%17.8%5.1 $96.26
1/15/20263,620,169 shares $395.61 million +17.8%17.8%5.05 $109.28
12/31/20253,072,640 shares $399.63 million -9.2%15.1%7.94 $130.06
12/15/20253,385,369 shares $509.87 million -5.8%16.6%8.59 $150.61
11/28/20253,594,043 shares $541.30 million -0.5%17.7%7.26 $150.61
11/14/20253,611,109 shares $462.44 million +3.0%17.7%6.77 $128.06
10/31/20253,504,577 shares $479.81 million +16.8%17.2%5.36 $136.91
10/15/20253,000,000 shares $350.73 million +6.4%11.9%4.5 $116.91
9/30/20252,820,000 shares $303.83 million -21.9%11.2%4 $107.74
9/15/20253,610,000 shares $440.56 million -0.6%14.4%4.5 $122.04
8/31/20253,630,000 shares $470.05 million -3.7%14.4%4.2 $129.49
8/15/20253,770,000 shares $476.38 million +3.6%15.1%4.3 $126.36
7/31/20253,640,000 shares $371.10 million +4.6%14.5%3.8 $101.95
7/15/20253,480,000 shares $284.28 million -6.2%14.0%3.1 $81.69
6/30/20253,710,000 shares $342.47 million -1.1%13.8%5.4 $92.31
6/15/20253,750,000 shares $242.14 million +3.0%15.0%3.3 $64.57
5/31/20253,640,000 shares $257.38 million +4.9%14.5%3.4 $70.71
5/15/20253,470,000 shares $220.73 million -2.8%13.9%3.1 $63.61
4/30/20253,570,000 shares $238.65 million +9.9%14.3%2.9 $66.85
4/15/20253,250,000 shares $332.22 million +17.8%13.0%3.2 $102.22
3/31/20252,760,000 shares $244.45 million +10.8%11.3%2.6 $88.57
3/15/20252,490,000 shares $245.19 million -1.2%10.2%2.5 $98.47
2/28/20252,520,000 shares $259.18 million -8.4%10.3%2.6 $102.85
2/15/20252,750,000 shares $209.96 million +28.5%11.4%3 $76.35
1/31/20252,140,000 shares $160.18 million No Change9.8%2.8 $74.85
How options let you do more with less capital (Ad)

Would you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fraction of the cost? That's the core advantage options offer traders at every level. The Beginner's Guide to Options breaks down leverage, income strategies, and real trade examples in plain English — including a little-known approach many traders use to reduce costs and improve profit potential. Download your free copy before this offer expires.tc pixel

Claim your free copy of The Beginner's Guide to Options now
1/15/20252,140,000 shares $154.96 million +2.9%9.7%3.1 $72.41
12/31/20242,080,000 shares $159.87 million -3.3%9.5%3.2 $76.86
12/15/20242,150,000 shares $162.17 million -5.7%9.8%3.5 $75.43
11/30/20242,280,000 shares $178.73 million -2.6%10.4%3.7 $78.39
11/15/20242,340,000 shares $160.13 million -10.0%10.7%4 $68.43
10/31/20242,600,000 shares $212.39 million +8.3%12.8%4.8 $81.69
10/15/20242,400,000 shares $143.98 million +8.6%12.6%5 $59.99
9/30/20242,210,000 shares $93.79 million -0.5%11.6%4.8 $42.44
9/15/20242,220,000 shares $84.07 million +1.4%11.6%5.1 $37.87
8/31/20242,190,000 shares $69.95 million +6.8%11.8%5.3 $31.94
8/15/20242,050,000 shares $67.42 million +7.9%11.1%4.9 $32.89
7/31/20241,900,000 shares $62.17 million +17.3%10.9%4.1 $32.72
7/15/20241,620,000 shares $55.89 million +32.8%9.8%2.9 $34.50
6/30/20241,220,000 shares $31.89 million +8.9%7.4%2.3 $26.14
6/15/20241,120,000 shares $32.23 million +6.7%6.8%2.5 $28.78
5/31/20241,050,000 shares $20.59 million -10.3%6.4%2.3 $19.61
5/15/20241,170,000 shares $24.76 million +0.9%7.2%2.7 $21.16
4/30/20241,160,000 shares $19.80 million +8.4%7.1%3 $17.07
4/15/20241,070,000 shares $10.57 million -2.7%6.6%5 $9.88
3/31/20241,100,000 shares $10.04 million +4.8%6.8%4.2 $9.13
3/15/20241,050,000 shares $12.61 million -4.6%6.5%3.8 $12.01
2/29/20241,100,000 shares $8.97 million -9.1%6.8%3.7 $8.15
2/15/20241,210,000 shares $5.38 million +14.2%7.5%3.1 $4.45
1/31/20241,060,000 shares $4.08 million +6.9%6.9%2.7 $3.85
1/15/2024991,900 shares $3.63 million +44.7%6.4%2.5 $3.66
12/31/2023685,700 shares $1.89 million +9.4%4.4%2 $2.75
12/15/2023626,600 shares $1.52 million -16.5%4.0%2 $2.43
11/30/2023750,100 shares $1.31 million +15.2%4.8%2.8 $1.75
11/15/2023651,400 shares $840.31 thousand -16.4%4.2%2.9 $1.29
10/31/2023779,100 shares $1.45 million +1.7%5.0%8.5 $1.86
10/15/2023765,900 shares $2.47 million +8.7%4.9%10.2 $3.23
9/30/2023704,500 shares $2.56 million -2.7%4.5%9.6 $3.64
9/15/2023724,300 shares $3.17 million +2.6%4.7%7.8 $4.38
8/31/2023705,700 shares $3.14 million +1.4%4.2%5.4 $4.45
8/15/2023696,200 shares $3.57 million -2.3%4.2%4.3 $5.13
7/31/2023712,600 shares $5.28 million -0.8%4.3%4.1 $7.41
7/15/2023718,200 shares $4.83 million -6.9%4.3%3.9 $6.72
6/30/2023771,500 shares $4.60 million -18.7%4.6%4.4 $5.96
6/15/2023949,200 shares $6.95 million +18.8%5.7%5.8 $7.32
5/31/2023798,700 shares $6.01 million +7.8%4.9%5.1 $7.52
5/15/2023740,800 shares $5.32 million No Change4.6%5.6 $7.18
12/15/20224,770,000 shares $1.34 million -25.2%2.8%2.8 $0.28
11/30/20226,380,000 shares $2.64 million -35.9%3.9%4.5 $0.41
11/15/20229,950,000 shares $8.76 million -8.1%6.0%9.6 $0.88
10/31/202210,830,000 shares $11.15 million -1.5%6.7%8.8 $1.03
10/15/202210,990,000 shares $9.42 million -4.0%6.8%8.8 $0.86
9/30/202211,450,000 shares $10.05 million +1.2%7.0%8.7 $0.88
9/15/202211,320,000 shares $11.32 million -5.0%7.0%6.3 $1.00
8/31/202211,920,000 shares $12.16 million -1.2%7.4%5.6 $1.02
8/15/202212,060,000 shares $28.94 million -19.8%7.5%5.3 $2.40
How options let you do more with less capital (Ad)

Would you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fraction of the cost? That's the core advantage options offer traders at every level. The Beginner's Guide to Options breaks down leverage, income strategies, and real trade examples in plain English — including a little-known approach many traders use to reduce costs and improve profit potential. Download your free copy before this offer expires.tc pixel

Claim your free copy of The Beginner's Guide to Options now
7/31/202215,030,000 shares $24.35 million +10.3%9.4%6.9 $1.62
7/15/202213,630,000 shares $21.54 million +9.9%8.5%5.8 $1.58
6/30/202212,400,000 shares $15.62 million +18.3%7.7%5.3 $1.26
6/15/202210,480,000 shares $15.20 million +11.4%6.5%4.6 $1.45
5/31/20229,410,000 shares $19.20 million +22.7%5.9%5.3 $2.04
5/15/20227,670,000 shares $15.72 million +61.8%4.8%4.8 $2.05
4/30/20224,740,000 shares $10.19 million -1.9%4.0%3.3 $2.15
4/15/20224,830,000 shares $12.61 million -1.0%4.1%3.4 $2.61
3/31/20224,880,000 shares $14.98 million +4.3%4.1%2.9 $3.07
3/15/20224,680,000 shares $12.36 million -6.0%4.0%2.7 $2.64
2/28/20224,980,000 shares $17.38 million +8.5%4.3%2.9 $3.49
2/15/20224,590,000 shares $16.98 million -14.8%3.9%2.6 $3.70
1/31/20225,390,000 shares $18.43 million -13.5%5.2%3 $3.42
1/15/20226,230,000 shares $25.17 million -20.9%5.6%3.8 $4.04
12/31/20217,880,000 shares $35.14 million +5.5%7.1%6.3 $4.46
12/15/20217,470,000 shares $36.30 million -4.2%6.7%5.7 $4.86
11/30/20217,800,000 shares $52.03 million -2.0%7.0%5.7 $6.67
11/15/20217,960,000 shares $62.25 million -7.4%7.2%5.9 $7.82
10/29/20218,600,000 shares $69.40 million +0.2%7.7%5.9 $8.07
10/15/20218,580,000 shares $66.84 million -11.9%7.7%5.7 $7.79

WGS Short Interest - Frequently Asked Questions

Short interest is the volume of GeneDx shares that have been sold short but have not yet been closed out or covered. As of September 15th, investors have sold 5,884,765 shares of WGS short. 26.37% of GeneDx's shares are currently sold short. Learn More on GeneDx's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. WGS shares currently have a short interest ratio of 12.1. Learn More on GeneDx's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 26.37% of GeneDx's floating shares are currently sold short.

GeneDx saw a decline in short interest in September. As of September 15th, there was short interest totaling 5,884,765 shares, a decline of 1.9% from the previous total of 6,001,270 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

26.37% of GeneDx's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare services" compare to GeneDx: Hinge Health Inc. (7.38%), Chemed Corporation (5.17%), Hims & Hers Health, Inc. (25.71%), RadNet, Inc. (12.95%), Billiontoone, Inc. (11.18%), LifeStance Health Group, Inc. (4.41%), CorVel Corp. (4.24%), Option Care Health, Inc. (8.22%), Aveanna Healthcare Holdings Inc. (2.66%), Privia Health Group, Inc. (4.07%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.21 billion), Invesco QQQ ($46.31 billion), iShares Russell 2000 ETF ($27.98 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($9.70 billion), Canadian Natural Resources Limited ($9.42 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($8.53 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.79 billion), and Financial Select Sector SPDR Fund ($7.74 billion). View all of the most shorted stocks.

Short selling WGS is an investing strategy that aims to generate trading profit from GeneDx as its price is falling. WGS shares are trading down $1.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for GeneDx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WGS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WGS, twice per month. The most recent reporting period available is September, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like WGS:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:WGS is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/24/2026. FINRA publishes updated short interest twice a month.
From Our Partners
They're not telling you how bad this could get
Valuations are stretched to levels seen only a handful of times in the past century, while a growing debt spir...
Parkview Capital Group | Sponsoredtc pixel
This AI fund posted a 34 percent annualized payout last month
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...
Investors Alley | Sponsoredtc pixel
A major gold reset could be closer than people think
For 50 years, Washington has held 8,133 tonnes of gold on its books at a fraction of today's market price. One...
Reagan Gold Group | Sponsoredtc pixel
First Look: Elon’s “Starphone”
Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to...
Stansberry Research | Sponsoredtc pixel
The end of AI data centers coming?
Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
How options let you do more with less capital
Would you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...
Base Camp Trading | Sponsoredtc pixel